The lawyers who have launched a class-action lawsuit against Bayer Pharmaceuticals as intra-uterine contraceptive device Mirena says women should “be fully apprised of [Mirena's] potential risks.”
Bernstain Liebhard LLP notes in a press release that a U.S. National Center for Health Statistics report showed that intrauterine device (IUD) use went from 3.5 percent of women between 2006 and 2010 to 6.4 percent between 2011 and 2013.
The study, says the firm, “comes as thousands of women are pursuing Mirena IUD lawsuit for serious complications they allegedly sustained due to its use. It is important that any young woman considering Mirena as her method of birth control be fully apprised of its potential risks.”
IUDs are anti-pregnancy devices that have both contraceptive and abortifacient potential.
This is not Bayer's first class-action lawsuit over contraceptives. In 2012, Bayer paid $1.6 billion to settle a lawsuit over side effects of Yaz/Yasmin contraceptive pills, and Mirena's side effects alone have led to thousands of lawsuits. In 2009, the company received a letter from the Food & Drug Administration saying that Bayer had underplayed risks and exaggerated benefits related to use of Mirena.